PURE Bioscience, Inc. (PURE) Free cash flow 2016–2023
PURE Bioscience, Inc. (PURE) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$3.3MFY2023 · since FY2016: -$5.4M → -$3.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -$3.3M | -32.5% |
| FY2022 | -$2.5M | -48.0% |
| FY2021 | -$1.7M | -376.3% |
| FY2020 | $611,000 | +120.4% |
| FY2019 | -$3.0M | +23.3% |
| FY2018 | -$3.9M | +18.1% |
| FY2017 | -$4.8M | +11.4% |
| FY2016 | -$5.4M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice